ZTS Class A Zoetis Inc. Class A Common Stock
NYSE · Pharmaceuticals · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 6, 2026ZTS स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
ZTS स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
Zoetis Inc. Class A Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses.
The firm is named Zoetis in allusion to the Greek-derived zoological term zoetic, meaning "pertaining to life". The company was owned by Pfizer until 2013.
History
1950s to 2000s
In the 1950s, Pfizer began research on several drugs, including oxytetracycline, which was found to be effective in livestock.
In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.
In 1988, the division was renamed Pfizer Animal Health.
In 1995, Pfizer acquired Norden Laboratories from GlaxoSmithKline for $1.45 billion, expanding its animal health division into small animal care, including pets.
Secondary research and development centres were opened in Kalamazoo, Michigan, in 2003.
In April 2003, Pfizer acquired Pharmacia Corporation for $60 billion in stock. Pfizer absorbed its animal health assets, which included the legacy operations of The Upjohn Company, into Pfizer Animal Health.
In December 2006, Pfizer Animal Health acquired Embrex, which provides inoculations for poultry against various diseases, for $155 million.
In March 2008, Pfizer Animal Health acquired Catapult Genetics, a developer of livestock DNA tests and gene markers, and Bovigen, which markets DNA technology.
In April 2008, Pfizer Animal Health acquired vaccine products from Schering-Plough.
In June 2009, Pfizer Animal Health acquired Vetnex Animal Health from ICICI Bank.
In October 2009, Pfizer acquired Wyeth, including its subsidiary Fort Dodge Animal Health, which was added to Pfizer Animal Health. Some assets were sold to Boehringer Ingelheim to gain regulatory approval for the transaction.
In May 2010, Pfizer Animal Health acquired Microtek, a developer of aquaculture vaccines.
2010s-present
In January 2011, Pfizer Animal Health acquired Synbiotics, a developer of immunodiagnostic tests for companion and food production animals, for $20 million.
In February 2011, Pfizer acquired King Pharmaceuticals; its Alpharma subsidiary was integrated into Pfizer Animal Health.
In June 2012, Pfizer Animal Health was renamed Zoetis.
In February 2013, Zoetis became a public company via an initial public offering, raising $2.2 billion. Most of the money raised through the IPO was used to pay off existing Pfizer debt. In June 2013, Pfizer divested itself of its remaining shares in Zoetis.
In February 2015, the company acquired a portfolio of pet drugs from Abbott Laboratories for approximately $255 million.
In July 2015, the company acquired KL Automation, a robotics company specializing in automation technology for poultry hatchery.
In November 2015, the company announced it would acquire Pharmaq, a developer of aquaculture treatments and diseases, for $765 million.
In August 2016, the company acquired Scandinavian Micro Biodevices for $80 million.
In April 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.
In July 2018, the company acquired Abaxis for $1.9 billion in cash.
In June 2022, Zoetis acquired Basepaws, a privately held genetics company.
In August 2022, the company acquired Newmetrica, a Scottish company that develops digital tools designed to measure health-related quality of life.
In September 2022, Zoetis acquired Jurox, which develops 150 medicines including Alfaxan.
In August 2023, the company opened a 1.4 million square foot facility on 145 acres in Lincoln, Nebraska.
In September 2023, Zoetis acquired Petmedix, a privately held Cambridge, UK-based company, to bring the benefits of species-specific antibody therapies to pet owners.
In December 2023, Zoetis acquired adivo, a German manufacturer of antibodies for pet medicine.
In October 2024, the company sold its medicated feed additive product portfolio and certain water-soluble products to Phibro Animal Health.
In February 2025, the United States Department of Agriculture granted Zoetis conditional approval to deploy its bird flu vaccine in poultry, after a bird flu outbreak had infected nearly 70 people in the USA, resulting in one death, with most cases occurring among farm workers exposed to infected poultry or cattle. In January 2025, the USDA announced plans to replenish its bird flu vaccine stockpile for poultry, aligning with the strain affecting commercial and wild bird populations, similar to efforts following major outbreaks in 2014 and 2015.
In November 2025, the company acquired Veterinary Pathology Group.
In March 2026, the company agreed to acquired the genomics business of Neogen.
In July 2026, the company agreed to acquire VitalRADS, a veterinary teleradiology platform.
Products
Zoetis' manufacturing network, includes 28 sites in 11 countries. Each facility is designed to meet chemical and infectious agent safety regulatory requirements. Many R&D operations are co-located with manufacturing sites, a collaboration that allows bringing new products to market faster.
Zoetis products include:
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | ZTS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 11.55Y औसत ≈35.9 | ≈35.9 | 31.0 | अल्पमूल्यित | |
| P/S (TTM) | 3.05Y औसत ≈9.5 | ≈9.5 | · | · | |
| P/B (MRQ) | 9.25Y औसत ≈18.1 | ≈18.1 | · | · | |
| मूल्य / FCF (TTM) | 12.25Y औसत ≈45.7 | ≈45.7 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 10.05Y औसत ≈33.9 | ≈33.9 | · | · | |
| EV / राजस्व (TTM) | 3.8 | · | · | · | |
| EV / FCF (TTM) | 15.3 | · | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 12.95Y औसत ≈180.4 | ≈180.4 | · | · | |
| PEG Ratio (PEG अनुपात) | ≈1.0 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | ZTS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| EBITDA Margin (EBITDA मार्जिन) | 5.1%5Y औसत ≈5.6% | ≈5.6% | 8.3% | कमजोर | |
| प्रीटैक्स मार्जिन (TTM) | 34.4%5Y औसत ≈33.7% | ≈33.7% | 15.0% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | 27.5%5Y औसत ≈27.0% | ≈27.0% | 10.4% | शीर्ष स्तर | |
| ROA (TTM) | 17.7%5Y औसत ≈16.2% | ≈16.2% | 9.8% | शीर्ष स्तर | |
| ROE (TTM) | 64.4%5Y औसत ≈52.6% | ≈52.6% | 25.3% | शीर्ष स्तर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | ZTS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | 2.95Y औसत ≈1.7 | ≈1.7 | 0.9 | उच्च ऋण | |
| वर्तमान अनुपात (MRQ) | 3.15Y औसत ≈2.9 | ≈2.9 | 1.6 | मजबूत तरलता | |
| त्वरित अनुपात (MRQ) | 1.65Y औसत ≈0.6 | ≈0.6 | 0.8 | मजबूत तरलता | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | 2.95Y औसत ≈1.6 | ≈1.6 | 0.9 | उच्च ऋण |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | ZTS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 2.3%5Y औसत ≈7.3% | ≈7.3% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 5.4%5Y औसत ≈6.7% | ≈6.7% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 7.2% | · | · | · | |
| EPS YoY | 10.1%5Y औसत ≈12.2% | ≈12.2% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 7.5%5Y औसत ≈10.5% | ≈10.5% | · | · | |
| EPS CAGR 3Y | 10.3%5Y औसत ≈11.0% | ≈11.0% | · | · | |
| EPS CAGR 5Y | 12.0% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | 8.1%5Y औसत ≈9.2% | ≈9.2% | · | · | |
| Net Income CAGR 5Y (शुद्ध आय CAGR 5Y) | 10.3% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | ZTS | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.65Y औसत ≈0.6 | ≈0.6 | 0.5 | शीर्ष स्तर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 1.15Y औसत ≈1.1 | ≈1.1 | 1.5 | कमजोर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 6.55Y औसत ≈6.9 | ≈6.9 | 5.6 | शीर्ष स्तर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$652.9K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
| एक्स-डेट | राशि | मुद्रा | यील्ड |
|---|---|---|---|
| जुल 20, 2026 | $0.53 | USD | ≈2.7% |
| अप्र 20, 2026 | $0.53 | USD | ≈1.7% |
| जन 20, 2026 | $0.53 | USD | ≈1.6% |
| अक्ट 31, 2025 | $0.50 | USD | ≈1.4% |
| जुल 18, 2025 | $0.50 | USD | ≈1.3% |
| अप्र 21, 2025 | $0.50 | USD | ≈1.3% |
| जन 21, 2025 | $0.50 | USD | ≈1.1% |
| अक्ट 31, 2024 | $0.43 | USD | ≈0.97% |
| जुल 18, 2024 | $0.43 | USD | ≈0.93% |
| अप्र 18, 2024 | $0.43 | USD | ≈1.1% |
| जन 18, 2024 | $0.43 | USD | ≈0.82% |
| अक्ट 31, 2023 | $0.38 | USD | ≈0.96% |
| जुल 20, 2023 | $0.38 | USD | ≈0.84% |
| अप्र 20, 2023 | $0.38 | USD | ≈0.80% |
| जन 19, 2023 | $0.38 | USD | ≈0.83% |
| अक्ट 31, 2022 | $0.33 | USD | ≈0.86% |
| जुल 20, 2022 | $0.33 | USD | ≈0.70% |
| अप्र 20, 2022 | $0.33 | USD | ≈0.61% |
| जन 19, 2022 | $0.33 | USD | ≈0.54% |
| अक्ट 28, 2021 | $0.25 | USD | ≈0.47% |
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 6, 2026 | $1.87 | $1.87 | -0.22% |
| 31 मार्च 2026 | $1.53 | $1.63 | -6.2% | |
| 31 दिसमबर 2025 | $1.48 | $1.42 | 4.5% | |
| 30 सितमबर 2025 | $1.70 | $1.64 | 3.8% | |
| 30 जून 2025 | $1.76 | $1.63 | 7.8% | |
| 31 मार्च 2025 | $1.48 | $1.41 | 5.2% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Cost of Revenue | $2.67B | $2.72B | $2.56B | $2.45B | $2.30B | $2.06B | $1.99B | $1.91B | $1.77B | $1.67B | $1.74B | $1.72B | |
| SG&A Expense | $2.38B | $2.32B | $2.15B | $2.01B | $2.00B | $1.73B | $1.64B | $1.48B | $1.33B | $1.36B | $1.53B | $1.64B | |
| Interest Expense | $222M | $225M | $239M | $221M | $224M | $231M | $223M | $206M | $175M | $166M | $124M | $117M | |
| Other Non-op | $-6M | $-4M | $-2M | $14M | $-4M | $-5M | $0 | $15M | $1M | $2M | $5M | $-3M | |
| Pretax Income | $3.36B | $3.13B | $2.94B | $2.66B | $2.49B | $2.00B | $1.80B | $1.69B | $1.52B | $1.23B | $545M | $820M | |
| Income Tax | $687M | $637M | $596M | $545M | $454M | $360M | $301M | $266M | $663M | $409M | $206M | $233M | |
| Net Income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| EPS (Basic) | $6.03 | $5.47 | $5.08 | $4.51 | $4.29 | $3.44 | $3.14 | $2.96 | $1.76 | $1.66 | $0.68 | $1.16 | |
| EPS (Diluted) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 | |
| Shares (Basic) | 443,443,000 | 454,200,000 | 461,172,000 | 468,891,000 | 474,348,000 | 475,502,000 | 478,128,000 | 483,063,000 | 489,918,000 | 495,715,000 | 499,707,000 | 501,055,000 | |
| Shares (Diluted) | 443,835,000 | 454,848,000 | 462,269,000 | 470,385,000 | 476,717,000 | 478,569,000 | 481,787,000 | 486,898,000 | 493,161,000 | 498,225,000 | 502,019,000 | 502,025,000 | |
| EBITDA | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.45B | $1.99B | $2.04B | $3.58B | $3.48B | $3.60B | $1.93B | $1.60B | $1.56B | $727M | $1.15B | $882M | |
| Short-term Investments | $0 | · | · | · | · | · | $0 | $99M | $0 | · | · | · | |
| Receivables | $1.41B | $1.32B | $1.30B | $1.22B | $1.13B | $1.01B | $1.09B | $1.04B | $998M | $913M | $937M | $980M | |
| Inventory | $2.46B | $2.31B | $2.56B | $2.35B | $1.92B | $1.63B | $1.41B | $1.39B | $1.43B | $1.50B | $1.47B | $1.29B | |
| Other Current Assets | $450M | $377M | $434M | $365M | $389M | $366M | $318M | $271M | $228M | $248M | $201M | $205M | |
| Current Assets | $6.77B | $5.99B | $6.34B | $7.51B | $6.93B | $6.61B | $4.75B | $4.40B | $4.22B | $3.39B | $3.83B | $3.46B | |
| PP&E (Net) | $3.69B | $3.39B | $3.20B | $2.75B | $2.42B | $2.20B | $1.94B | $1.66B | $1.44B | $1.38B | $1.31B | $1.32B | |
| PP&E (Gross) | $6.61B | $6.03B | $5.80B | $5.05B | $4.49B | $4.15B | $3.68B | $3.26B | $2.91B | $2.74B | $2.52B | $2.46B | |
| Accum. Depreciation | $2.94B | $2.63B | $2.59B | $2.30B | $2.07B | $1.95B | $1.74B | $1.60B | $1.47B | $1.36B | $1.21B | $1.15B | |
| Goodwill | $2.77B | $2.72B | $2.76B | $2.75B | $2.68B | $2.69B | $2.59B | $2.52B | $1.51B | $1.48B | $1.46B | $976M | |
| Intangibles | $998M | $1.13B | $1.34B | $1.38B | $1.47B | $1.71B | $1.89B | $2.05B | $1.27B | $1.23B | $1.19B | $727M | |
| Other Non-current Assets | $327M | $250M | $206M | $147M | $111M | $106M | $98M | $94M | $75M | $73M | $49M | $48M | |
| Total Assets | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Accounts Payable | $445M | $433M | $411M | $405M | $436M | $457M | $301M | $313M | $261M | $265M | $293M | $290M | |
| Accrued Liabilities | $852M | $746M | $683M | $682M | $710M | $556M | $543M | $487M | $432M | $464M | $676M | $475M | |
| Short-term Debt | $0 | $0 | $3M | $2M | $0 | $4M | $0 | $9M | $0 | $0 | $0 | $0 | |
| Current Liabilities | $2.17B | $3.41B | $1.89B | $3.17B | $1.80B | $2.17B | $1.81B | $1.22B | $1.09B | $1.12B | $1.78B | $1.09B | |
| Capital Leases | $197M | $174M | $188M | $186M | $151M | $163M | $164M | $0 | · | · | · | · | |
| Deferred Tax | $137M | $167M | $146M | $142M | $320M | $378M | $434M | $474M | $380M | $244M | $264M | $277M | |
| Other Non-current Liabilities | $250M | $222M | $237M | $217M | $239M | $270M | $229M | $187M | $201M | $248M | $251M | $207M | |
| Total Liabilities | $12.07B | $9.47B | $9.29B | $10.52B | $9.36B | $9.84B | $8.84B | $8.59B | $6.80B | $6.15B | $6.82B | $5.25B | |
| Long-term Debt | $9.04B | $6.57B | $6.56B | $7.90B | $6.59B | $7.20B | $6.45B | $6.44B | $4.95B | $4.47B | $4.86B | $3.62B | |
| Total Debt | $9.04B | $6.57B | $6.57B | $7.90B | $6.59B | $7.20B | $6.45B | $6.45B | $4.95B | $4.47B | $4.86B | · | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.10B | $1.18B | $1.13B | $1.09B | $1.07B | $1.06B | $1.04B | $1.03B | $1.01B | $1.02B | $1.01B | $958M | |
| Retained Earnings | $13.80B | $11.97B | $10.29B | $8.67B | $7.19B | $5.66B | $4.43B | $3.27B | $2.11B | $1.48B | $876M | $709M | |
| Treasury Stock | $10.69B | $7.45B | $5.60B | $4.54B | $2.95B | $2.23B | $2.04B | $1.49B | $852M | $421M | $203M | $0 | |
| AOCI | $-804M | $-940M | $-839M | $-817M | $-764M | $-730M | $-726M | $-629M | $-505M | $-598M | $-622M | $-361M | |
| Stockholders' Equity | $3.42B | $4.77B | $5.00B | $4.41B | $4.54B | $3.77B | $2.71B | $2.19B | $1.79B | $1.50B | $1.07B | $1.31B | |
| Liabilities + Equity | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Shares Outstanding | 424,927,535 | 448,473,073 | 458,367,358 | 463,808,059 | 472,574,090 | 475,317,751 | 475,528,210 | 479,562,326 | 486,130,461 | 492,855,297 | 497,400,113 | 501,327,524 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M | |
| Stock-based Comp | $83M | $74M | $60M | $62M | $58M | $59M | $67M | $53M | $44M | $37M | $43M | $32M | |
| Deferred Tax | $-52M | $-338M | $-61M | $-286M | $-80M | $-62M | $-79M | $-112M | $127M | $-55M | $-85M | $-49M | |
| Amort. of Intangibles | $157M | $170M | $185M | $193M | $204M | $230M | $237M | $157M | $100M | $95M | $64M | $63M | |
| Restructuring | $49M | $43M | $46M | $6M | $33M | $8M | $33M | $26M | $13M | $2M | $301M | $17M | |
| Other Non-cash | $-287M | $234M | $-481M | $-443M | $-250M | $50M | $-105M | $113M | $69M | $-330M | $168M | $-144M | |
| Operating Cash Flow | $2.90B | $2.95B | $2.35B | $1.91B | $2.21B | $2.13B | $1.79B | $1.79B | $1.35B | $713M | $664M | $626M | |
| CapEx | $621M | $655M | $732M | $586M | $477M | $453M | $460M | $338M | $224M | $216M | $224M | $180M | |
| Investing Cash Flow | $-748M | $-315M | $-777M | $-883M | $-458M | $-572M | $-504M | $-2.26B | $-270M | $-214M | $-1.11B | $-187M | |
| Net Debt Issued | $-1.35B | $0 | $-1.35B | $0 | $-600M | $-500M | $0 | $0 | $-750M | $-400M | · | · | |
| Stock Repurchased | $3.23B | $1.86B | $1.09B | $1.59B | $743M | $250M | $626M | $698M | $500M | $300M | $203M | $0 | |
| Net Stock Activity | $-3.23B | $-1.86B | $-1.09B | $-1.59B | $-743M | $-250M | $-626M | $-698M | $-500M | $-300M | $-203M | · | |
| Financing Cash Flow | $-1.87B | $-2.66B | $-3.11B | $-904M | $-1.86B | $123M | $-951M | $533M | $-251M | $-903M | $755M | $-154M | |
| Net Change in Cash | $325M | $-54M | $-1.54B | $96M | $-119M | $1.67B | $332M | $38M | $837M | $-427M | $272M | $272M | |
| Taxes Paid | $715M | $892M | $754M | $638M | $548M | $418M | $418M | $336M | $455M | $408M | $224M | $278M | |
| Free Cash Flow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B | $1.67B | $1.33B | $1.45B | $1.12B | $497M | $440M | $446M | |
| Levered FCF | $2.11B | $2.12B | $1.43B | $1.15B | $1.55B | $1.48B | $1.15B | $1.28B | $1.02B | $386M | $363M | $362M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | 24.5% | 24.0% | 24.5% | 16.3% | 16.8% | 7.1% | 12.2% | |
| Pretax Margin | 35.5% | 33.9% | 34.4% | 32.9% | 32.0% | 29.9% | 28.8% | 29.0% | 28.7% | 25.1% | 11.4% | 17.1% | |
| EBITDA Margin | 5.1% | 5.4% | 5.8% | 5.8% | 5.8% | 6.6% | 6.6% | 5.3% | 4.6% | 4.9% | 4.2% | 4.3% | |
| ROA | 18.0% | 17.4% | 16.1% | 14.7% | 14.8% | 13.0% | 13.4% | 14.7% | 10.6% | 10.5% | 4.7% | · | |
| ROE | 66.0% | 50.9% | 49.9% | 47.2% | 49.0% | 50.6% | 58.6% | 66.4% | 52.9% | 64.3% | 28.5% | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 | 3.0 | 2.6 | 3.6 | 3.9 | 3.0 | 2.2 | · | |
| Quick Ratio | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 | 0.5 | 0.6 | 0.9 | 2.3 | 1.5 | 1.2 | · | |
| Debt / Equity | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 | 1.9 | 2.4 | 3.0 | 2.8 | 3.0 | 4.6 | · | |
| LT Debt / Equity | 2.7 | 1.1 | 1.3 | 1.5 | 1.5 | 1.7 | 2.2 | 2.9 | 2.8 | 3.0 | 4.2 | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | · | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.1 | 1.3 | 1.4 | 1.4 | 1.4 | 1.2 | 1.1 | 1.3 | · | |
| Receivables Turnover | 6.5 | 7.1 | 6.8 | 6.9 | 7.2 | 6.4 | 5.9 | 5.7 | 5.6 | 5.3 | 5.0 | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.84 | $10.64 | $10.90 | $9.50 | $9.61 | $7.93 | $5.69 | $4.56 | $3.64 | $3.02 | $2.15 | · | |
| Revenue / Share | $21.33 | $20.35 | $18.48 | $17.18 | $16.31 | $13.95 | $12.99 | $11.96 | $10.76 | $9.81 | $9.49 | $9.53 | |
| Cash Flow / Share | $6.54 | $6.49 | $5.09 | $4.06 | $4.64 | $4.44 | $3.73 | $3.68 | $2.73 | $1.43 | $1.32 | $1.25 | |
| Cash / Share | · | · | · | · | · | · | · | · | $3.22 | $1.48 | $2.32 | · | |
| Dividend Paid / Share | $2.03 | $1.80 | $1.56 | $1.35 | $1.07 | $0.85 | $0.69 | $0.54 | $0.44 | $0.39 | $0.34 | $0.30 | |
| EPS (TTM) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.3% | 8.3% | 5.7% | 3.9% | 16.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.4% | 6.0% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 10.1% | 7.9% | 12.9% | 5.1% | 24.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 10.3% | 8.6% | 14.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 12.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 7.5% | 6.1% | 10.9% | 3.8% | 24.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 8.1% | 6.9% | 12.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Net Income TTM | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| Market Cap | $53.46B | $73.07B | $90.47B | $67.97B | $115.32B | $78.67B | $62.94B | $41.02B | $35.02B | $26.38B | $23.84B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | $38.41B | $30.12B | $27.54B | · | |
| P/E | 20.9 | 29.8 | 38.9 | 32.6 | 57.1 | 48.4 | 42.6 | 29.2 | 41.2 | 32.4 | 70.5 | 37.1 | |
| P/S | 5.6 | 7.9 | 10.6 | 8.4 | 14.8 | 11.8 | 10.1 | 7.0 | 6.6 | 5.4 | 5.0 | · | |
| P/B | 16.1 | 15.3 | 18.1 | 15.4 | 25.4 | 20.9 | 23.2 | 18.8 | 19.8 | 17.7 | 22.3 | · | |
| P / Tangible Book | · | 79.5 | 100.5 | 243.6 | 298.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | 18.4 | 24.7 | 38.4 | 35.5 | 52.1 | 37.0 | 35.1 | 22.9 | 26.0 | 37.0 | 35.9 | · | |
| P / FCF | 23.4 | 31.8 | 55.8 | 51.3 | 66.4 | 47.0 | 47.1 | 28.3 | 31.2 | 53.1 | 54.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 158.7 | 125.5 | 138.4 | · | |
| EV / FCF | · | · | · | · | · | · | · | · | 34.2 | 60.6 | 62.6 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 7.2 | 6.2 | 5.8 | · | |
| Earnings Yield | 4.8% | 3.4% | 2.6% | 3.1% | 1.8% | 2.1% | 2.4% | 3.4% | 2.4% | 3.1% | 1.4% | 2.7% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.47B | $2.26B | $2.39B | $2.40B | $2.47B | $2.20B | $2.32B | $2.39B | $2.36B | $2.19B | $2.21B | $2.15B | $2.18B | $2.00B | $2.04B | $2.00B | |
| Cost of Revenue | $673M | $641M | $712M | $683M | $664M | $618M | $707M | $701M | $668M | $643M | $728M | $638M | $607M | $588M | $653M | $607M | |
| SG&A Expense | $592M | $588M | $619M | $579M | $614M | $574M | $625M | $565M | $581M | $547M | $565M | $525M | $556M | $505M | $514M | $501M | |
| Interest Expense | $61M | $62M | $57M | $58M | $53M | $54M | $51M | $57M | $59M | $58M | $59M | $59M | $58M | $63M | $62M | $53M | |
| Other Non-op | $-2M | $-1M | $-8M | $0 | $-1M | $3M | $1M | $-2M | $2M | $-5M | $5M | $-4M | $2M | $-5M | $6M | $1M | |
| Pretax Income | $866M | $758M | $761M | $887M | $912M | $773M | $732M | $874M | $780M | $747M | $650M | $717M | $872M | $697M | $592M | $667M | |
| Income Tax | $175M | $157M | $158M | $166M | $186M | $171M | $151M | $182M | $156M | $148M | $127M | $121M | $202M | $146M | $132M | $139M | |
| Net Income | $691M | $601M | $603M | $721M | $726M | $602M | $581M | $682M | $624M | $599M | $525M | $596M | $671M | $552M | $461M | $529M | |
| EPS (Basic) | $1.65 | $1.42 | $1.38 | $1.63 | $1.63 | $1.34 | $1.28 | $1.51 | $1.37 | $1.31 | $1.15 | $1.29 | $1.45 | $1.19 | $0.99 | $1.13 | |
| EPS (Diluted) | $1.65 | $1.42 | $1.37 | $1.63 | $1.63 | $1.34 | $1.29 | $1.50 | $1.37 | $1.31 | $1.14 | $1.29 | $1.45 | $1.19 | $0.98 | $1.13 | |
| Shares (Basic) | 417,600,000 | 422,100,000 | · | 442,900,000 | 445,100,000 | 447,600,000 | · | 452,900,000 | 455,500,000 | 458,000,000 | · | 460,300,000 | 461,900,000 | 463,500,000 | · | 467,800,000 | |
| Shares (Diluted) | 417,700,000 | 422,400,000 | · | 443,200,000 | 445,500,000 | 448,000,000 | · | 453,500,000 | 456,000,000 | 458,800,000 | · | 461,400,000 | 462,900,000 | 464,600,000 | · | 469,100,000 | |
| EBITDA | $119M | $119M | · | $124M | $123M | $119M | · | $121M | $127M | $126M | · | $124M | $121M | $120M | · | $115M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.48B | $1.94B | · | $2.08B | $1.44B | $1.72B | · | $1.71B | $1.57B | $1.98B | · | $1.75B | $1.72B | $2.11B | · | $2.51B | |
| Short-term Investments | $200M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | $1.57B | $1.51B | $1.59B | $1.54B | $1.54B | $1.36B | $1.32B | $1.41B | $1.38B | $1.29B | · | $1.26B | $1.32B | $1.19B | · | $1.19B | |
| Inventory | $2.57B | $2.55B | $2.43B | $2.46B | $2.44B | $2.37B | $2.31B | $2.42B | $2.45B | $2.65B | · | $2.74B | $2.70B | $2.56B | · | $2.30B | |
| Other Current Assets | $535M | $477M | $436M | $493M | $509M | $430M | $377M | $427M | $467M | $440M | · | $467M | $443M | $411M | · | $552M | |
| Current Assets | $6.36B | $6.47B | $6.77B | $6.58B | $5.92B | $5.88B | $5.99B | $6.28B | $6.20B | $6.36B | · | $6.22B | $6.18B | $6.27B | · | $6.55B | |
| PP&E (Net) | $3.76B | $3.72B | $3.68B | $3.60B | $3.54B | $3.44B | $3.39B | $3.30B | $3.20B | $3.25B | · | $3.09B | $3.01B | $2.91B | · | $2.62B | |
| PP&E (Gross) | · | · | $6.61B | · | · | · | $6.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $3.07B | $3.00B | $2.92B | $2.87B | $2.80B | $2.70B | $2.63B | $2.66B | $2.59B | $2.67B | · | $2.53B | $2.45B | $2.37B | · | $2.23B | |
| Goodwill | $2.77B | $2.78B | $2.77B | $2.76B | $2.76B | $2.72B | $2.72B | $2.74B | $2.74B | $2.76B | $2.76B | $2.76B | $2.71B | $2.74B | $2.75B | $2.69B | |
| Intangibles | $918M | $959M | $998M | $1.04B | $1.07B | $1.08B | $1.13B | $1.19B | $1.23B | $1.29B | · | $1.40B | $1.25B | $1.31B | · | $1.32B | |
| Other Non-current Assets | $384M | $351M | $328M | $293M | $267M | $232M | $250M | $215M | $210M | $227M | · | $216M | $173M | $143M | · | $161M | |
| Total Assets | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Accounts Payable | $452M | $507M | $487M | $410M | $508M | $420M | $433M | $404M | $420M | $405M | · | $388M | $464M | $424M | · | $373M | |
| Accrued Liabilities | · | · | $852M | · | · | · | $746M | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $24M | · | $2M | $2M | $3M | · | $3M | |
| Current Liabilities | $2.06B | $2.05B | $2.23B | $1.81B | $3.37B | $3.38B | $3.41B | $1.70B | $1.80B | $1.91B | · | $1.61B | $1.77B | $1.92B | · | $2.88B | |
| Capital Leases | $190M | $193M | $196M | $204M | $210M | $173M | $174M | $181M | $181M | $184M | · | $191M | $188M | $180M | · | $186M | |
| Deferred Tax | $122M | $130M | $139M | $147M | $156M | $161M | $167M | $172M | $175M | $136M | · | $160M | $121M | $131M | · | $256M | |
| Other Non-current Liabilities | $220M | $219M | $248M | $264M | $274M | $220M | $222M | $220M | $222M | $228M | · | $259M | $217M | $216M | · | $239M | |
| Total Liabilities | $11.93B | $11.92B | $12.14B | $9.76B | $9.50B | $9.44B | $9.47B | $9.12B | $9.21B | $9.30B | · | $9.03B | $9.13B | $9.26B | · | $9.01B | |
| Long-term Debt | · | · | $9.04B | $7.07B | $6.58B | $6.58B | $6.57B | · | · | · | · | $6.55B | $6.55B | $6.56B | · | $6.56B | |
| Total Debt | $9.05B | $9.04B | · | $7.07B | $6.58B | $6.58B | · | $6.57B | $6.56B | $6.59B | · | $6.55B | $6.56B | $6.56B | · | $6.56B | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $5M | |
| Paid-in Capital | $1.13B | $1.10B | $1.10B | $1.22B | $1.20B | $1.18B | $1.18B | $1.16B | $1.15B | $1.13B | · | $1.12B | $1.10B | $1.08B | · | $1.07B | |
| Retained Earnings | $14.65B | $14.18B | $13.74B | $13.59B | $12.87B | $12.38B | $11.97B | $11.81B | $11.12B | $10.70B | · | $10.14B | $9.54B | $9.04B | · | $8.53B | |
| Treasury Stock | $11.85B | $11.29B | $10.69B | $8.61B | $8.23B | $7.89B | $7.45B | $6.89B | $6.46B | $5.93B | · | $5.37B | $5.13B | $4.81B | · | $4.14B | |
| AOCI | $-796M | $-772M | $-834M | $-818M | $-877M | $-1.02B | $-940M | $-851M | $-845M | $-841M | · | $-814M | $-895M | $-828M | · | $-809M | |
| Stockholders' Equity | $3.15B | $3.23B | $3.33B | $5.40B | $4.98B | $4.66B | $4.77B | $5.23B | $4.97B | $5.06B | · | $5.08B | $4.62B | $4.49B | · | $4.66B | |
| Liabilities + Equity | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Shares Outstanding | 414,154,046 | 420,348,495 | 424,927,535 | 441,464,339 | 443,945,593 | 446,040,205 | 448,473,073 | 451,549,789 | 453,812,361 | 456,947,205 | · | 459,524,713 | 460,750,652 | 462,495,343 | · | 466,442,095 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $119M | $119M | $121M | $124M | $124M | $119M | $123M | $121M | $127M | $126M | $126M | $124M | $121M | $120M | $119M | $115M | |
| Stock-based Comp | $26M | $25M | $22M | $22M | $22M | $17M | $19M | $18M | $19M | $18M | $17M | $17M | $17M | $9M | $16M | $15M | |
| Deferred Tax | $-33M | $34M | $-48M | $-16M | $-7M | $14M | $-152M | $-42M | $-101M | $-43M | $-21M | $-14M | $-34M | $8M | $-176M | $-34M | |
| Amort. of Intangibles | $38M | $39M | $38M | $39M | $40M | $40M | $42M | $42M | $42M | $44M | $44M | $46M | $48M | $47M | $46M | $48M | |
| Restructuring | $75M | $20M | $16M | $4M | · | · | $-3M | $-2M | $37M | $11M | $8M | $13M | $5M | $20M | $1M | · | |
| Other Non-cash | · | $-378M | · | · | · | $-199M | · | · | · | $-105M | · | · | · | $-140M | · | · | |
| Operating Cash Flow | $655M | $401M | $893M | $938M | $486M | $515M | $905M | $951M | $502M | $595M | $897M | $724M | $183M | $549M | $741M | $526M | |
| CapEx | $117M | $110M | $161M | $133M | $178M | $178M | $216M | $167M | $132M | $140M | $198M | $145M | $166M | $223M | $171M | $154M | |
| Investing Cash Flow | $-300M | $-87M | $-166M | $-160M | $-247M | $-203M | $126M | $-178M | $-132M | $-131M | $-210M | $-271M | $-80M | $-216M | $-438M | $-124M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-1.35B | · | · | |
| Stock Repurchased | $584M | $606M | $2.06B | $394M | $338M | $443M | $553M | $433M | $533M | $339M | $235M | $250M | $324M | $283M | $405M | $377M | |
| Net Stock Activity | · | $-606M | · | · | · | $-443M | · | · | · | $-339M | · | · | · | $-283M | · | · | |
| Financing Cash Flow | $-813M | $-840M | $-495M | $-134M | $-564M | $-677M | $-745M | $-628M | $-763M | $-524M | $-397M | $-416M | $-494M | $-1.80B | $780M | $-529M | |
| Net Change in Cash | $-465M | $-509M | $228M | $649M | $-286M | $-332M | $273M | $140M | $-401M | $-66M | $287M | $37M | $-392M | $-1.47B | $1.07B | $-145M | |
| Taxes Paid | $380M | $50M | $133M | $107M | $428M | $60M | $235M | $176M | $422M | $59M | $168M | $128M | $438M | $20M | $167M | $155M | |
| Free Cash Flow | · | $291M | · | · | · | $438M | · | · | · | $455M | · | · | · | $326M | · | · | |
| Levered FCF | · | $242M | · | · | · | $396M | · | · | · | $408M | · | · | · | $276M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.0% | 26.6% | · | 30.0% | 29.2% | 28.4% | · | 28.6% | 26.4% | 27.4% | · | 27.7% | 30.8% | 27.6% | · | 26.4% | |
| Pretax Margin | 35.1% | 33.5% | · | 37.0% | 36.7% | 36.5% | · | 36.6% | 33.0% | 34.1% | · | 33.3% | 40.0% | 34.8% | · | 33.3% | |
| EBITDA Margin | 4.8% | 5.3% | · | 5.2% | 5.0% | 5.4% | · | 5.1% | 5.4% | 5.8% | · | 5.8% | 5.5% | 6.0% | · | 5.7% | |
| ROA | 4.7% | 4.1% | · | 4.9% | 5.0% | 4.4% | · | 4.8% | 4.5% | 4.3% | · | 4.3% | 4.9% | 4.0% | · | 3.9% | |
| ROE | 17.0% | 15.2% | · | 13.6% | 14.4% | 13.0% | · | 13.2% | 13.0% | 12.5% | · | 12.2% | 14.6% | 12.1% | · | 11.3% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 3.2 | · | 3.6 | 1.8 | 1.7 | · | 3.7 | 3.5 | 3.3 | · | 3.9 | 3.5 | 3.3 | · | 2.3 | |
| Quick Ratio | 1.6 | 1.7 | · | 2.0 | 0.9 | 0.9 | · | 1.8 | 1.6 | 1.7 | · | 1.9 | 1.7 | 1.7 | · | 1.3 | |
| Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.3 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.4 | |
| LT Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.1 | 1.1 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.1 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.6 | 1.6 | · | 1.6 | 1.7 | 1.7 | · | 1.8 | 1.7 | 1.8 | · | 1.8 | 1.7 | 1.7 | · | 1.7 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.60 | $7.69 | · | $12.23 | $11.21 | $10.44 | · | $11.59 | $10.94 | $11.07 | · | $11.05 | $10.04 | $9.72 | · | $10.00 | |
| Revenue / Share | $5.91 | $5.36 | · | $5.42 | $5.52 | $4.96 | · | $5.27 | $5.18 | $4.77 | · | $4.66 | $4.71 | $4.30 | · | $4.27 | |
| Cash Flow / Share | · | $0.95 | · | · | · | $1.31 | · | · | · | $1.30 | · | · | · | $1.18 | · | · | |
| Cash / Share | $3.56 | $4.62 | · | $4.72 | $3.23 | $3.86 | · | $3.80 | $3.47 | $4.32 | · | $3.82 | $3.73 | $4.56 | · | $5.37 | |
| Dividend / Share | $0.53 | $0.53 | · | $0.00 | $0.50 | $0.50 | · | $0.00 | $0.43 | $0.43 | · | $0.00 | $0.38 | $0.38 | · | $0.00 | |
| EPS (TTM) | $6.07 | $6.05 | · | $5.89 | $5.76 | $5.50 | · | $5.32 | $5.11 | $5.19 | · | $4.91 | $4.75 | $4.42 | · | $4.38 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.52B | $9.52B | · | $9.39B | $9.38B | $9.26B | · | $9.15B | $8.91B | $8.73B | · | $8.37B | $8.22B | $8.09B | · | $8.01B | |
| Net Income TTM | $2.62B | $2.65B | · | $2.63B | $2.59B | $2.49B | · | $2.43B | $2.34B | $2.39B | · | $2.28B | $2.21B | $2.07B | · | $2.07B | |
| Market Cap | $29.76B | $49.69B | · | $64.60B | $69.23B | $73.44B | · | $88.22B | $78.67B | $77.32B | · | $79.95B | $79.35B | $76.98B | · | $69.17B | |
| Enterprise Value | $37.13B | $56.79B | · | $69.58B | $74.38B | $78.30B | · | $93.08B | $83.66B | $81.93B | · | $84.75B | $84.19B | $81.43B | · | $73.22B | |
| P/E | 11.8 | 19.5 | · | 24.8 | 27.1 | 29.9 | · | 36.7 | 33.9 | 32.6 | · | 35.4 | 36.3 | 37.7 | · | 33.9 | |
| P/S | 3.1 | 5.2 | · | 6.9 | 7.4 | 7.9 | · | 9.6 | 8.8 | 8.9 | · | 9.6 | 9.7 | 9.5 | · | 8.6 | |
| P/B | 9.5 | 15.4 | · | 12.0 | 13.9 | 15.8 | · | 16.9 | 15.8 | 15.3 | · | 15.7 | 17.2 | 17.1 | · | 14.8 | |
| P / Tangible Book | · | · | · | 40.5 | 60.5 | 85.7 | · | 67.7 | 78.6 | 77.0 | · | 87.1 | 120.4 | 174.2 | · | 106.1 | |
| P / Cash Flow | · | 123.9 | · | · | · | 125.1 | · | · | · | 129.9 | · | · | · | 140.2 | · | · | |
| EV / Revenue | 3.9 | 6.0 | · | 7.4 | 7.9 | 8.5 | · | 10.2 | 9.4 | 9.4 | · | 10.1 | 10.2 | 10.1 | · | 9.1 | |
| Earnings Yield | 8.5% | 5.1% | · | 4.0% | 3.7% | 3.3% | · | 2.7% | 2.9% | 3.1% | · | 2.8% | 2.8% | 2.7% | · | 2.9% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B |
| शुद्ध आय | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B |
| तनुकरणित EPS | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 |
| वर्तमान अनुपात | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 |
| त्वरित अनुपात | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B |
संस्थागत मालिक (13F) 1581 फाइलर्स · $35.8B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 170 (-31 पिछली तिमाही की तुलना में) | 318 (+136 पिछली तिमाही की तुलना में) | 521 (-88 पिछली तिमाही की तुलना में) | 585 (-42 पिछली तिमाही की तुलना में) | -6.7M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6011802148 | 47780974 | 16.82% | शेयर |
| BlackRock, Inc. | $2833452809 | 39430181 | 7.93% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $1870370930 | 26027984 | 5.23% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1714611578 | 23860445 | 4.80% | शेयर |
| STATE STREET CORP | $1413322575 | 19667723 | 3.95% | शेयर |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1142064009 | 15892903 | 3.19% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $951789721 | 13289622 | 2.66% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $677201094 | 9423895 | 1.89% | शेयर |
| MORGAN STANLEY | $638034469 | 8878849 | 1.78% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $519929070 | 4398351 | 1.45% | शेयर |
| NORDEA INVESTMENT MANAGEMENT AB | $471698956 | 6592578 | 1.32% | शेयर |
| JANUS HENDERSON GROUP PLC | $437568419 | 3701747 | 1.22% | शेयर |
| DEUTSCHE BANK AG\ | $420505821 | 5851737 | 1.18% | शेयर |
| NORTHERN TRUST CORP | $398264934 | 5542234 | 1.11% | शेयर |
| Invesco Ltd. | $396884095 | 5523018 | 1.11% | शेयर |
| FIL Ltd | $386734926 | 5381783 | 1.08% | शेयर |
| NORGES BANK | $337012405 | 4689847 | 0.94% | शेयर |
| VAN ECK ASSOCIATES CORP | $305558780 | 4252140 | 0.85% | शेयर |
| FLOSSBACH VON STORCH SE | $302600879 | 4210978 | 0.85% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $287726761 | 4003981 | 0.80% | शेयर |
| Amundi | $286622090 | 3988618 | 0.80% | शेयर |
| BANK OF AMERICA CORP /DE/ | $282045207 | 3924926 | 0.79% | शेयर |
| UBS Group AG | $261803299 | 3643241 | 0.73% | शेयर |
| Legal & General Group Plc | $256352499 | 3567388 | 0.72% | शेयर |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $255637351 | 3557436 | 0.72% | शेयर |
| CIBC Private Wealth Group LLC | $246008713 | 1681306 | 0.69% | शेयर |
| Bank of New York Mellon Corp | $238741846 | 3322319 | 0.67% | शेयर |
| GOLDMAN SACHS GROUP INC | $229937577 | 3199799 | 0.64% | शेयर |
| CITADEL ADVISORS LLC | $229108579 | 3188263 | 0.64% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $225456582 | 3137442 | 0.63% | शेयर |
| JPMORGAN CHASE & CO | $192268534 | 2624825 | 0.54% | शेयर |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $173617784 | 2416056 | 0.49% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $170008975 | 2365836 | 0.48% | शेयर |
| Ruane, Cunniff & Goldfarb L.P. | $169108138 | 2353300 | 0.47% | शेयर |
| BARCLAYS PLC | $165474682 | 2302737 | 0.46% | शेयर |
| Qube Research & Technologies Ltd | $163792869 | 2279333 | 0.46% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $156216242 | 2173278 | 0.44% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $152540744 | 2122749 | 0.43% | शेयर |
| JANE STREET GROUP, LLC | $144534676 | 2011337 | 0.40% | शेयर |
| BRANDES INVESTMENT PARTNERS, LP | $138737455 | 1930651 | 0.39% | शेयर |
| HSBC HOLDINGS PLC | $132131854 | 1839811 | 0.37% | शेयर |
| BLS Capital Fondsmaeglerselskab A/S | $131538868 | 1830488 | 0.37% | शेयर |
| ROYAL BANK OF CANADA | $131385000 | 1828326 | 0.37% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $130336722 | 1813759 | 0.36% | शेयर |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | $130169165 | 1864087 | 0.36% | शेयर |
| WELLS FARGO & COMPANY/MN | $130014751 | 1809278 | 0.36% | शेयर |
| Man Group plc | $129707516 | 1805003 | 0.36% | शेयर |
| Nuveen, LLC | $129322602 | 1799647 | 0.36% | शेयर |
| BANQUE PICTET & CIE SA | $128888455 | 1793605 | 0.36% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $125134922 | 1741371 | 0.35% | शेयर |
कार्यकर्ता और 5%+ मालिक 2 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×7 फाइलिंग | 8 जुलाई 2016 | · | प्रारंभिक फाइलिंग | · | SEC |
| Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC, Scott D. Ferguson ×2 फाइलिंग | 4 फ़रवरी 2015 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 52 इनसाइडर्स · 30 अधिकारी · 21 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Kristin C Peck | Chief Executive Officer | 10 जुलाई 2026 A | 105068 | 0 | 2 | $-2540972 |
| James Saccaro | EVP, CFO & COO | 31 अगस्त 2026 A | · | 0 | 0 | $0 |
| Wetteny Joseph | Chief Financial Officer | 10 जुलाई 2026 A | 22113 | 0 | 0 | $0 |
| Paul Herendeen | Exec. V.P. and CFO | 19 जुलाई 2016 A | · | 0 | 0 | $0 |
| Julie Fuller | Executive Vice President | 30 सितमबर 2026 M | 1588 | 0 | 0 | $0 |
| Kevin Esch | Executive Vice President | 10 जुलाई 2026 A | 578 | 0 | 0 | $0 |
| Keith Sarbaugh | Executive Vice President | 10 जुलाई 2026 A | 3346 | 0 | 0 | $0 |
| Rimma Driscoll | Executive Vice President | 10 जुलाई 2026 A | 5715 | 0 | 0 | $0 |
| Astorga Jeannette Ferran | Executive Vice President | 10 जुलाई 2026 A | 1684 | 0 | 0 | $0 |
| Abhay U Nayak | Executive Vice President | 10 जुलाई 2026 A | 1965 | 0 | 0 | $0 |
| Roxanne Lagano | Executive Vice President | 10 जुलाई 2026 A | 15632 | 0 | 0 | $0 |
| Jamie Brannan | Executive Vice President | 19 फ़रवरी 2026 M | 3290 | 0 | 0 | $0 |
| Nicholas Ashton | Executive Vice President | 19 फ़रवरी 2026 M | 1822 | 0 | 0 | $0 |
| Robert J Polzer | Executive Vice President | 10 अक्टूबर 2025 A | 5120 | 0 | 0 | $0 |
| Soria Ester Banque | Executive Vice President | 4 अक्टूबर 2024 A | 588 | 0 | 0 | $0 |
| Wafaa Mamilli | Executive Vice President | 4 अक्टूबर 2024 A | 6685 | 0 | 0 | $0 |
| Heidi C. Chen | Executive Vice President | 5 अप्रैल 2024 A | 31293 | 0 | 0 | $0 |
| Glenn David | Executive Vice President | 13 जनवरी 2023 A | 46572 | 0 | 0 | $0 |
| Timothy J Bettington | Executive Vice President | 7 अक्टूबर 2022 A | · | 0 | 0 | $0 |
| Roman Trawicki | Executive Vice President | 16 मार्च 2022 M | 8218 | 0 | 0 | $0 |
| Catherine A. Knupp | Executive Vice President | 10 नवमबर 2021 S | 43642 | 0 | 0 | $0 |
| Sherry N Pudloski | Executive Vice President | 8 अक्टूबर 2021 A | · | 0 | 0 | $0 |
| Robert Edward Kelly | Executive Vice President | 3 मई 2021 M | 8300 | 0 | 0 | $0 |
| James Michael Mcfarland | Executive Vice President | 9 अप्रैल 2021 A | 2547 | 0 | 0 | $0 |
| Clinton A. Lewis Jr. | Executive Vice President | 16 दिसमबर 2019 M | 27904 | 0 | 0 | $0 |
| Andrew Fenton | Executive Vice President | 6 दिसमबर 2019 M | 23073 | 0 | 0 | $0 |
| Alejandro Bernal | Executive Vice President | 27 फ़रवरी 2018 M | 11417 | 0 | 0 | $0 |
| Sandra J. Beaty | Executive Vice President | 30 अप्रैल 2015 A | 6721 | 0 | 0 | $0 |
| Joyce J. Lee | Executive Vice President | 9 अप्रैल 2015 A | 3838 | 0 | 0 | $0 |
| Stefan Weiskopf | Executive Vice President | 27 फ़रवरी 2015 A | 3658 | 0 | 0 | $0 |
| Mark Stetter | निदेशक | 17 सितमबर 2026 A | 1572 | 0 | 0 | $0 |
| Frank A Damelio | निदेशक | 7 अगस्त 2026 G | 14808 | 1 | 0 | $501344 |
| Michael B Mccallister | निदेशक | 10 जून 2026 G | 0 | 1 | 0 | $233280 |
| Louise M Parent | निदेशक | 20 मई 2026 M | 28394 | 0 | 0 | $0 |
| Paul Bisaro | निदेशक | 13 मई 2026 P | 27862 | 1 | 0 | $151760 |
| Gregory Norden | निदेशक | 9 मार्च 2026 G | 0 | 0 | 0 | $0 |
| Vanessa Broadhurst | निदेशक | 19 फ़रवरी 2026 M | 3920 | 0 | 0 | $0 |
| Antoinette Renee Leatherberry | निदेशक | 19 फ़रवरी 2026 M | 5280 | 0 | 0 | $0 |
| Willie M Reed | निदेशक | 19 फ़रवरी 2026 M | 12864 | 0 | 0 | $0 |
| Gavin Hattersley | निदेशक | 19 फ़रवरी 2026 M | 3354 | 0 | 0 | $0 |
| Khosla Sanjay | निदेशक | 19 फ़रवरी 2026 A | 1892 | 0 | 0 | $0 |
| Stephanie Tilenius | निदेशक | 18 फ़रवरी 2026 A | · | 0 | 0 | $0 |
| Robert W Scully | निदेशक | 21 मई 2025 M | 21489 | 0 | 0 | $0 |
| Linda Rhodes | निदेशक | 21 मई 2024 M | 11192 | 0 | 0 | $0 |
| Juan Ramon Alaix | निदेशक | 20 मई 2021 D | 215129 | 0 | 0 | $0 |
| William C Steere JR | निदेशक | 20 मई 2021 M | 35074 | 0 | 0 | $0 |
| Charles H Hill | निदेशक | 6 फ़रवरी 2013 P | 5000 | 0 | 0 | $0 |
| Amy Schulman | निदेशक | 6 फ़रवरी 2013 P | 5000 | 0 | 0 | $0 |
| Douglas E. Giordano | निदेशक | 6 फ़रवरी 2013 P | 5000 | 0 | 0 | $0 |
| Geno J Germano | निदेशक | 6 फ़रवरी 2013 P | 5000 | 0 | 0 | $0 |
| Pfizer Inc. | 10% मालिक | 24 जून 2013 C | 0 | 0 | 0 | $0 |
| Richard A. Passov | · | 15 जुलाई 2014 A | 3706 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 154 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IHE · iShares Trust | 3.78% | 840871 SH | 11 सितमबर 2026 | दैनिक |
| SMRI · EA Series Trust | 1.83% | 152486 NS | 31 जुलाई 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.82% | 246575 NS | 31 जुलाई 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1.56% | 37663 SH | 1 अक्टूबर 2026 | दैनिक |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.56% | 194540 SH | 1 अक्टूबर 2026 | दैनिक |
| CVAR · ETF Opportunities Trust | 1.40% | 7761 NS | 31 जुलाई 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.08% | 2889 NS | 31 जुलाई 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.93% | 221136 SH | 1 अक्टूबर 2026 | दैनिक |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.74% | 17243 NS | 31 जुलाई 2026 | N-PORT |
| IWP · iShares Trust | 0.71% | 1867940 SH | 11 सितमबर 2026 | दैनिक |
| COWZ · Pacer Funds Trust | 0.62% | 1502929 NS | 31 जुलाई 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0.59% | 2890747 SH | 19 अगस्त 2026 | दैनिक |
| FLAG · Global X Funds | 0.56% | 123 NS | 31 जुलाई 2026 | N-PORT |
| ESLV · Strategy Shares | 0.52% | 951 NS | 31 जुलाई 2026 | N-PORT |
| PABU · iShares Trust | 0.51% | 174679 SH | 11 सितमबर 2026 | दैनिक |
| IYH · iShares Trust | 0.49% | 246300 SH | 11 सितमबर 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.47% | 200057 NS | 31 जुलाई 2026 | N-PORT |
| RCGE · EA Series Trust | 0.47% | 6141 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.45% | 1264118 SH | 19 अगस्त 2026 | दैनिक |
| IXJ · iShares Trust | 0.39% | 219915 SH | 10 सितमबर 2026 | दैनिक |
| CURE · Direxion Shares ETF Trust | 0.37% | 8250 NS | 31 जुलाई 2026 | N-PORT |
| NULC · Nushares ETF Trust | 0.35% | 3218 NS | 31 जुलाई 2026 | N-PORT |
| ESUM · Strategy Shares | 0.33% | 7829 NS | 31 जुलाई 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 0.31% | 57270 NS | 31 जुलाई 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.31% | 10926000 | 1 अक्टूबर 2026 | दैनिक |
| SUSA · iShares Trust | 0.30% | 164110 SH | 11 सितमबर 2026 | दैनिक |
| VFVA · VANGUARD WELLINGTON FUND | 0.29% | 33789 SH | 19 अगस्त 2026 | दैनिक |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0.28% | 754260 SH | 1 अक्टूबर 2026 | दैनिक |
| RECS · Columbia ETF Trust I | 0.28% | 212600 NS | 31 जुलाई 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.26% | 8177172 SH | 19 अगस्त 2026 | दैनिक |
| EVUS · iShares Trust | 0.25% | 13282 SH | 11 सितमबर 2026 | दैनिक |
| IMCV · iShares Trust | 0.25% | 39931 SH | 11 सितमबर 2026 | दैनिक |
| DUHP · Dimensional ETF Trust | 0.24% | 375907 NS | 31 जुलाई 2026 | N-PORT |
| QDF · FlexShares Trust | 0.23% | 67413 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.23% | 1725551 SH | 11 सितमबर 2026 | दैनिक |
| IMCB · iShares Trust | 0.21% | 49261 SH | 11 सितमबर 2026 | दैनिक |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 2668324 SH | 1 अक्टूबर 2026 | दैनिक |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 206683 NS | 31 जुलाई 2026 | N-PORT |
| EUSA · iShares, Inc. | 0.19% | 50884 SH | 11 सितमबर 2026 | दैनिक |
| LRND · New York Life Investments ETF Trust | 0.18% | 9465 NS | 31 जुलाई 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.18% | 5589000 | 1 अक्टूबर 2026 | दैनिक |
| DGRO · iShares Trust | 0.18% | 1051645 SH | 11 सितमबर 2026 | दैनिक |
| IMCG · iShares Trust | 0.18% | 97153 SH | 11 सितमबर 2026 | दैनिक |
| SIZE · iShares Trust | 0.18% | 10276 SH | 11 सितमबर 2026 | दैनिक |
| XOEF · iShares Trust | 0.17% | 526 SH | 11 सितमबर 2026 | दैनिक |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.17% | 7877000 | 1 अक्टूबर 2026 | दैनिक |
| LCOW · Pacer Funds Trust | 0.16% | 529 NS | 31 जुलाई 2026 | N-PORT |
| CATH · Global X Funds | 0.15% | 25943 NS | 31 जुलाई 2026 | N-PORT |
| ESGU · iShares Trust | 0.15% | 364501 SH | 10 सितमबर 2026 | दैनिक |
| ESMV · iShares Trust | 0.15% | 158 SH | 10 सितमबर 2026 | दैनिक |
| GSY · Invesco Actively Managed Exchange-T… | 0.15% | 5769000 | 1 अक्टूबर 2026 | दैनिक |
| PALC · Pacer Funds Trust | 0.15% | 3973 NS | 31 जुलाई 2026 | N-PORT |
| QUAL · iShares Trust | 0.14% | 888569 SH | 11 सितमबर 2026 | दैनिक |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.13% | 175000 | 1 अक्टूबर 2026 | दैनिक |
| VIG · VANGUARD SPECIALIZED FUNDS | 0.13% | 2368421 SH | 19 अगस्त 2026 | दैनिक |
| VYM · VANGUARD WHITEHALL FUNDS | 0.13% | 1680027 SH | 19 अगस्त 2026 | दैनिक |
| NUDV · Nushares ETF Trust | 0.13% | 834 NS | 31 जुलाई 2026 | N-PORT |
| USXF · iShares Trust | 0.12% | 24978 SH | 11 सितमबर 2026 | दैनिक |
| ESG · FlexShares Trust | 0.12% | 2010 NS | 31 जुलाई 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 6837 NS | 31 जुलाई 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0.11% | 11940 SH | 1 अक्टूबर 2026 | दैनिक |
| IVE · iShares Trust | 0.10% | 695597 SH | 11 सितमबर 2026 | दैनिक |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.10% | 14060 SH | 1 अक्टूबर 2026 | दैनिक |
| IQSU · New York Life Investments ETF Trust | 0.10% | 4253 NS | 31 जुलाई 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0.10% | 3598101 SH | 19 अगस्त 2026 | दैनिक |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.10% | 96479 SH | 19 अगस्त 2026 | दैनिक |
| CHRI · Global X Funds | 0.10% | 102 NS | 31 जुलाई 2026 | N-PORT |
| LGDX · Tidal Trust III | 0.10% | 1814 NS | 31 जुलाई 2026 | N-PORT |
| IUSV · iShares Trust | 0.10% | 368059 SH | 11 सितमबर 2026 | दैनिक |
| REVS · Columbia ETF Trust I | 0.09% | 3986 NS | 31 जुलाई 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 10356 SH | 1 अक्टूबर 2026 | दैनिक |
| SUSL · iShares Trust | 0.09% | 14854 SH | 11 सितमबर 2026 | दैनिक |
| DSI · iShares Trust | 0.09% | 64531 SH | 11 सितमबर 2026 | दैनिक |
| HAPI · Harbor ETF Trust | 0.08% | 5320 NS | 31 जुलाई 2026 | N-PORT |
| AQLT · iShares Trust | 0.08% | 3693 SH | 10 सितमबर 2026 | दैनिक |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.08% | 55607 SH | 1 अक्टूबर 2026 | दैनिक |
| WRND · New York Life Investments ETF Trust | 0.08% | 109 NS | 31 जुलाई 2026 | N-PORT |
| MPLY · Strategy Shares | 0.08% | 158 NS | 31 जुलाई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.08% | 5377 NS | 31 जुलाई 2026 | N-PORT |
| ESGG · FlexShares Trust | 0.07% | 1064 NS | 31 जुलाई 2026 | N-PORT |
| EGLE · Global X Funds | 0.07% | 21 NS | 31 जुलाई 2026 | N-PORT |
| IWF · iShares Trust | 0.07% | 1245265 SH | 11 सितमबर 2026 | दैनिक |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.07% | 521663 SH | 19 अगस्त 2026 | दैनिक |
| IWS · iShares Trust | 0.06% | 135157 SH | 11 सितमबर 2026 | दैनिक |
| PRF · Invesco Exchange-Traded Fund Trust | 0.06% | 85655 SH | 1 अक्टूबर 2026 | दैनिक |
| CRBN · iShares Trust | 0.06% | 9378 SH | 10 सितमबर 2026 | दैनिक |
| TOPC · iShares Trust | 0.06% | 258 SH | 11 सितमबर 2026 | दैनिक |
| ACVF · ETF Opportunities Trust | 0.06% | 1125 NS | 31 जुलाई 2026 | N-PORT |
| USCL · iShares Trust | 0.06% | 22073 SH | 10 सितमबर 2026 | दैनिक |
| HQGO · Lattice Strategies Trust | 0.06% | 354 NS | 31 जुलाई 2026 | N-PORT |
| XTR · Global X Funds | 0.05% | 34 NS | 31 जुलाई 2026 | N-PORT |
| XYLG · Global X Funds | 0.05% | 452 NS | 31 जुलाई 2026 | N-PORT |
| XRMI · Global X Funds | 0.05% | 344 NS | 31 जुलाई 2026 | N-PORT |
| XVV · iShares Trust | 0.05% | 4833 SH | 10 सितमबर 2026 | दैनिक |
| XCLR · Global X Funds | 0.05% | 24 NS | 31 जुलाई 2026 | N-PORT |
| ILCV · iShares Trust | 0.05% | 9460 SH | 11 सितमबर 2026 | दैनिक |
| PTLC · Pacer Funds Trust | 0.05% | 21352 NS | 31 जुलाई 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.05% | 57993 NS | 31 जुलाई 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.05% | 7112 NS | 31 जुलाई 2026 | N-PORT |
| XYLD · Global X Funds | 0.05% | 21020 NS | 31 जुलाई 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.05% | 10888932 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.05% | 95134 SH | 19 अगस्त 2026 | दैनिक |
| TOV · EA Series Trust | 0.05% | 1758 NS | 31 जुलाई 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.05% | 34718 NS | 31 जुलाई 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0.05% | 36 NS | 31 जुलाई 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.05% | 64727 SH | 1 अक्टूबर 2026 | दैनिक |
| IVV · iShares Trust | 0.05% | 5283923 SH | 11 सितमबर 2026 | दैनिक |
| ILCB · iShares Trust | 0.05% | 8221 SH | 9 सितमबर 2026 | दैनिक |
| SPUU · Direxion Shares ETF Trust | 0.05% | 1582 NS | 31 जुलाई 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.05% | 10102 NS | 31 जुलाई 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.04% | 72430 SH | 1 अक्टूबर 2026 | दैनिक |
| PBP · Invesco Exchange-Traded Fund Trust | 0.04% | 2457 SH | 1 अक्टूबर 2026 | दैनिक |
| DFAU · Dimensional ETF Trust | 0.04% | 70832 NS | 31 जुलाई 2026 | N-PORT |
| IYY · iShares Trust | 0.04% | 18056 SH | 10 सितमबर 2026 | दैनिक |
| IWB · iShares Trust | 0.04% | 290521 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.04% | 115640 SH | 10 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.04% | 544118 SH | 11 सितमबर 2026 | दैनिक |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.04% | 9771 SH | 1 अक्टूबर 2026 | दैनिक |
| ILCG · iShares Trust | 0.04% | 17162 SH | 11 सितमबर 2026 | दैनिक |
| VV · VANGUARD INDEX FUNDS | 0.04% | 440643 SH | 19 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.04% | 11984400 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.04% | 69366 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.04% | 35465 SH | 19 अगस्त 2026 | दैनिक |
| HCMT · Direxion Shares ETF Trust | 0.04% | 2917 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.04% | 17007 NS | 31 जुलाई 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.04% | 32772 NS | 31 जुलाई 2026 | N-PORT |
| TOK · iShares Trust | 0.04% | 1209 SH | 11 सितमबर 2026 | दैनिक |
| PHDG · Invesco Actively Managed Exchange-T… | 0.04% | 325 SH | 1 अक्टूबर 2026 | दैनिक |
| URTH · iShares, Inc. | 0.03% | 37976 SH | 10 सितमबर 2026 | दैनिक |
| DFSU · Dimensional ETF Trust | 0.03% | 9950 NS | 31 जुलाई 2026 | N-PORT |
| ACWI · iShares Trust | 0.03% | 138514 SH | 9 सितमबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.03% | 356907 SH | 19 अगस्त 2026 | दैनिक |
| TILT · FlexShares Trust | 0.03% | 8216 NS | 31 जुलाई 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.03% | 69465 NS | 31 जुलाई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.02% | 2228 NS | 31 जुलाई 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0.02% | 5737 NS | 31 जुलाई 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 54015 SH | 19 अगस्त 2026 | दैनिक |
| IWD · iShares Trust | 0.02% | 198738 SH | 11 सितमबर 2026 | दैनिक |
| QDEF · FlexShares Trust | 0.02% | 1148 NS | 31 जुलाई 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0.00% | 3000 | 30 सितमबर 2026 | दैनिक |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 66000 | 1 अक्टूबर 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.00% | 6792 NS | 31 जुलाई 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| VCEB · VANGUARD WORLD FUND | · | · | 30 जुलाई 2026 | दैनिक |
ZTS विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
12-महीने का मूल्य लक्ष्य
14 विश्लेषक · 2026-09-28माध्य लक्ष्य $96.00 +37.8%
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| JNJ | · | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।